EUVIMEDEUVIMED entdecken
Open Access

Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma

Fitria Sari Wulandari, Chih-Yang Wang, Dana R Crawford, Yung-Ning Yang, Chee-Kin Then, Sachin Kumar, Fat-Moon Suk, Lin-Yi Huang, Yu-Chen Sh Yang, Zi-Lin Li, Ya-Jung Shih, Hoai Tran Tu und 7 weitere

International Journal of Medical Sciences · 2026

DOI: 10.7150/ijms.125066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2026. Verfasst von Fitria Sari Wulandari und 18 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Integrin alphaVbeta3, Bile Duct Neoplasms, Thyroxine. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaIntegrin alphaVbeta3Bile Duct NeoplasmsThyroxineHumansAnimalsMiceCell ProliferationErbB ReceptorsCell Line, TumorSignal TransductionXenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticMolecular Targeted TherapyEpidermal Growth FactorDoxorubicin

Stichwörter der Autor:innen

cholangiocarcinomaepidermal growth factorepidermal growth factor receptor (EGFR)integrin αvβ3nano-tetracprogrammed death ligand 1 (PD-L1)thyroxine

Substanzen

Integrin alphaVbeta3ThyroxineErbB ReceptorsEGFR protein, humanEpidermal Growth FactorDoxorubicin

Autor:innen und Institutionen

  • Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
  • Department of Surgery, Division of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
  • TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
  • Department of Pediatrics, E-DA Hospital, I-Shou University, Kaohsiung 82445, Taiwan.
  • School of Medicine, college of Medicine, I-Shou University, Kaohsiung 82445, Taiwan.

Zitieren

APA

Wulandari, F. S., Wang, C. Y., Crawford, D. R., Yang, Y. N., Then, C. K., Kumar, S., Suk, F. M., Huang, L. Y., Yang, Y. S., Li, Z. L., Shih, Y. J., Tu, H. T., Wang, K., Phu, H. D., Lin, C. M., Xuan, D. T. M., Solomon, D. D., Lin, H. Y., & Whang-Peng, J. (2026). Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.125066

Vancouver

Wulandari FS, Wang CY, Crawford DR, Yang YN, Then CK, Kumar S, et al. Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma. International Journal of Medical Sciences. 2026. doi:10.7150/ijms.125066

BibTeX
@article{Wulandari2026,
  author = {Wulandari, Fitria Sari and Wang, Chih-Yang and Crawford, Dana R and Yang, Yung-Ning and Then, Chee-Kin and Kumar, Sachin and Suk, Fat-Moon and Huang, Lin-Yi and Yang, Yu-Chen Sh and Li, Zi-Lin and Shih, Ya-Jung and Tu, Hoai Tran and Wang, Kuan and Phu, Hoang Dang and Lin, Chun-Mao and Xuan, Do Thi Minh and Solomon, Dahlak Daniel and Lin, Hung-Yun and Whang-Peng, Jacqueline},
  title = {Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma},
  journal = {International Journal of Medical Sciences},
  year = {2026},
  doi = {10.7150/ijms.125066}
}
Kostenlos starten →